eCommerce(800) 886-5369
Contact
eCommerce(800) 886-5369
BlueAllyBlueAlly
Contact

Strengthening Cybersecurity for a Biotech Company

A clinical-stage genetic medicine company was scaling fast, along with its attack surface. With sensitive research data and intellectual property to protect, the organization asked BlueAlly to perform a thorough penetration test and translate the results into concrete steps to reduce risk.

Biotech

The Client

A biotech firm operating in clinical development engaged BlueAlly to assess the security of a large, distributed environment: approximately 2,300 internal IPs and 27 external IPs.

Tablet, medical and doctors in hospital for research on diagnosis, treatment or surgery planning, Telehealth, professional and healthcare team with digital technology for online service in clinic.

The Client

A biotech firm operating in clinical development engaged BlueAlly to assess the security of a large, distributed environment: approximately 2,300 internal IPs and 27 external IPs.

The Problem

Rapid growth and a complex research ecosystem had outpaced previous assessments. The client needed a current, evidence-based view of vulnerabilities that could threaten operations, compromise sensitive systems, or create compliance exposure—without disrupting daily work across labs, cloud, and core infrastructure.

The BlueAlly Solution

BlueAlly executed a comprehensive penetration test across in-scope internal and external assets. Security engineers combined automated discovery with targeted manual validation to confirm impact and prioritize remediation.

Representative tooling included Nessus Professional; Nmap (custom and built-in scripts); TestSSLServer and SSLScan for TLS analysis; Wireshark for traffic inspection; Metasploit Framework for exploitation validation; Retina Network Security Scanner and Nexpose for coverage across hosts and services; Angry IP Scanner for rapid host discovery; and hping3 and Masscan for packet crafting and high-speed scanning. Findings were documented with reproducible evidence, risk ratings, and practical remediation guidance.

The Results

Risk Assessment

Critical risks identified and prioritized

The assessment uncovered 3 critical-risk, 6 high-risk, and 6 medium-risk vulnerabilities, giving the client a clear, risk-based roadmap for immediate action.

Edge Protection

Protection against unauthorized access and data compromise

Tests revealed unprivileged access to sensitive systems, enabling the client to strengthen access controls and reduce paths to research data and core services.

Least Priviledged Access

Mitigation of email spoofing exposure

By identifying spoofable email issues, the client was able to harden email security policies and reduce phishing and BEC risk.

Compliance

Improved compliance readiness

Addressing the identified weaknesses enhanced overall resilience and supported the organization’s regulatory compliance posture.